Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.

Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.

Item
http://www.wikidata.org/entity/Q33335178
A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT.Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis.Central pontine myelinolysis: a case report and clinical-pathological review.Hypertension and renal dysfunction in long-term liver transplant recipients.Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.Sirolimus as the main immunosuppressant in the early postoperative period following liver transplantation: a report of six cases and review of the literature.The role and value of sirolimus administration in kidney and liver transplantation.Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma.mTOR inhibitors for hepatocellular cancer: a forward-moving target.Central pontine myelinolysis following pediatric living donor liver transplantation: a case report and review of literature.A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients.What is the best immunosuppressant combination in terms of antitumor effect in hepatocellular carcinoma?Conversion From Sirolimus to Everolimus in Long-Term Liver Graft Recipients.The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials.Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent.A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.
P2860

Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.

Item
http://www.wikidata.org/entity/Q33335178
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Experience with the use of sir ...... nhibitors are contraindicated.
@ast
Experience with the use of sir ...... nhibitors are contraindicated.
@en
Experience with the use of sir ...... nhibitors are contraindicated.
@nl
type
label
Experience with the use of sir ...... nhibitors are contraindicated.
@ast
Experience with the use of sir ...... nhibitors are contraindicated.
@en
Experience with the use of sir ...... nhibitors are contraindicated.
@nl
prefLabel
Experience with the use of sir ...... nhibitors are contraindicated.
@ast
Experience with the use of sir ...... nhibitors are contraindicated.
@en
Experience with the use of sir ...... nhibitors are contraindicated.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Experience with the use of sir ...... nhibitors are contraindicated.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921